Search Results - "Descamps, O S"

Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization by Descamps, O.S, Tenoutasse, S, Stephenne, X, Gies, I, Beauloye, V, Lebrethon, M.-C, De Beaufort, C, De Waele, K, Scheen, A, Rietzschel, E, Mangano, A, Panier, J.P, Ducobu, J, Langlois, M, Balligand, J.-L, Legat, P, Blaton, V, Muls, E, Van Gaal, L, Sokal, E, Rooman, R, Carpentier, Y, De Backer, G, Heller, F.R

“…Abstract Since heterozygous familial hypercholesterolemia (HeFH) is a disease that exposes the individual from birth onwards to severe hypercholesterolemia…”
Get full text

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society by Cuchel, Marina, Bruckert, Eric, Ginsberg, Henry N, Raal, Frederick J, Santos, Raul D, Hegele, Robert A, Kuivenhoven, Jan Albert, Nordestgaard, Børge G, Descamps, Olivier S, Steinhagen-Thiessen, Elisabeth, Tybjærg-Hansen, Anne, Watts, Gerald F, Averna, Maurizio, Boileau, Catherine, Borén, Jan, Catapano, Alberico L, Defesche, Joep C, Hovingh, G Kees, Humphries, Steve E, Kovanen, Petri T, Masana, Luis, Pajukanta, Päivi, Parhofer, Klaus G, Ray, Kausik K, Stalenhoef, Anton F H, Stroes, Erik, Taskinen, Marja-Riitta, Wiegman, Albert, Wiklund, Olov, Chapman, M John

“…Homozygous familial hypercholesterolaemia (HoFH) is a rare life-threatening condition characterized by markedly elevated circulating levels of low-density…”
Get full text

The changing pattern of cirrhosis in Belgium: a study based on two cohorts prospectively collected 15 years apart by Kaze, E, Descamps, O S, Henrion, J

“…The epidemiology of cirrhosis is evolving over the past decades in Western countries. The aim of this study was to assess the changes in the epidemiology of…”
Get more information

D-DIMER CUT-OFF ADJUSTED TO AGE PERFORMS BETTER FOR EXCLUSION OF PULMONARY EMBOLISM IN PATIENTS OVER 75 YEARS by Laruelle, M, Descamps, OS, Lesage, V

“…Introduction: A D-dimer (DD) test improves the diagnosis of PE (PE) when combined with clinical scores. However, as DD levels increase physiologically with…”
Get full text

Co-administration of ezetimibe and simvastatin in acute myocardial infarction by Chenot, F., Montant, P. F., Marcovitch, O., Blaimont, M., De Meester, A., Descamps, O. S.

“…Background  Recent trials in acute myocardial infarction indicate that intensive and early statin therapy that lowers low‐density lipoprotein cholesterol…”
Get full text

Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia by Descamps, O. S., Gilbeau, J-P., Leysen, X., Van Leuven, F., Heller, F. R.

“…Among patients with severe hypercholesterolaemia and a family history of early cardiovascular disease, we assessed whether patients with mutations of…”
Get full text

Statins and Clarithromycin : a dangerous combination. Case report and review of the literature by Werion, A, Komuta, M, Descamps, O S, Henrion, J

Get more information

Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia by Descamps, O. S., Gilbeau, J.-P., Luwaert, R., Heller, F. R.

“…Background In the present study we assessed whether the presence of genetic mutations typical of familial hypercholesterolaemia (FH) was associated with…”
Get full text

Case report: acute pancreatitis induced by Clozapine by Bayard, J-M F, Descamps, O S, Evrard, S, Dumonceau, J M, Servais, L, Zingir, Z, Adams, S, Dassy, V, Stillemans, E, Seutin, A, Titeca, P, Titeca, J

“…Two percent of acute pancreatitis are drug induced. In the present paper, we reported the case of a 39 year-old patient with chronic-hallucinatory…”
Get more information

The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia by Descamps, Olivier S, Leysen, Xavier, Van Leuven, Fred, Heller, Francis R

“…Differentiating FH from other causes of hypercholesterolemia has important clinical and therapeutic implications but is often not possible by standard clinical…”
Get full text

Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM by Nordestgaard, Børge G., Langlois, Michel R., Langsted, Anne, Chapman, M. John, Aakre, Kristin M., Baum, Hannsjörg, Borén, Jan, Bruckert, Eric, Catapano, Alberico, Cobbaert, Christa, Collinson, Paul, Descamps, Olivier S., Duff, Christopher J., von Eckardstein, Arnold, Hammerer-Lercher, Angelika, Kamstrup, Pia R., Kolovou, Genovefa, Kronenberg, Florian, Mora, Samia, Pulkki, Kari, Remaley, Alan T., Rifai, Nader, Ros, Emilio, Stankovic, Sanja, Stavljenic-Rukavina, Ana, Sypniewska, Grazyna, Watts, Gerald F., Wiklund, Olov, Laitinen, Päivi

“…The joint consensus panel of the European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)…”
Get full text

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM by Langlois, Michel R, Nordestgaard, Børge G, Langsted, Anne, Chapman, M John, Aakre, Kristin M, Baum, Hannsjörg, Borén, Jan, Bruckert, Eric, Catapano, Alberico, Cobbaert, Christa, Collinson, Paul, Descamps, Olivier S, Duff, Christopher J, von Eckardstein, Arnold, Hammerer-Lercher, Angelika, Kamstrup, Pia R, Kolovou, Genovefa, Kronenberg, Florian, Mora, Samia, Pulkki, Kari, Remaley, Alan T, Rifai, Nader, Ros, Emilio, Stankovic, Sanja, Stavljenic-Rukavina, Ana, Sypniewska, Grazyna, Watts, Gerald F, Wiklund, Olov, Laitinen, Päivi

“…The joint consensus panel of the European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)…”
Get more information

Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease by Gylling, Helena, Plat, Jogchum, Turley, Stephen, Ginsberg, Henry N, Ellegård, Lars, Jessup, Wendy, Jones, Peter J, Lütjohann, Dieter, Maerz, Winfried, Masana, Luis, Silbernagel, Günther, Staels, Bart, Borén, Jan, Catapano, Alberico L, De Backer, Guy, Deanfield, John, Descamps, Olivier S, Kovanen, Petri T, Riccardi, Gabriele, Tokgözoglu, Lale, Chapman, M. John

“…Abstract Objective This EAS Consensus Panel critically appraised evidence relevant to the benefit to risk relationship of functional foods with added plant…”
Get full text

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management by Hegele, Robert A, Prof, Ginsberg, Henry N, Prof, Chapman, M John, Prof, Nordestgaard, Børge G, Prof, Kuivenhoven, Jan Albert, PhD, Averna, Maurizio, Prof, Borén, Jan, Prof, Bruckert, Eric, Prof, Catapano, Alberico L, Prof, Descamps, Olivier S, PhD, Hovingh, G Kees, PhD, Humphries, Steve E, Prof, Kovanen, Petri T, Prof, Masana, Luis, Prof, Pajukanta, Päivi, PhD, Parhofer, Klaus G, Prof, Raal, Frederick J, Prof, Ray, Kausik K, Prof, Santos, Raul D, PhD, Stalenhoef, Anton F H, Prof, Stroes, Erik, Prof, Taskinen, Marja-Riitta, Prof, Tybjærg-Hansen, Anne, Prof, Watts, Gerald F, Prof, Wiklund, Olov, Prof

“…Summary Plasma triglyceride concentration is a biomarker for circulating triglyceride-rich lipoproteins and their metabolic remnants. Common mild-to-moderate…”
Get full text

Understanding IMPROVE-IT and the cardinal role of LDL-C lowering in CVD prevention by Laufs, Ulrich, Descamps, Olivier S, Catapano, Alberico L, Packard, Chris J

Get full text

PERSONALIZED APPROACH TO LIPID-LOWERING THERAPY by Scheen, A J, Descamps, O S

“…Individualized therapeutic strategy of dyslipidemias, classically relies upon a phenotypic approach. The pattern of lipid profile allows the choice of the best…”
Get more information

Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives by Sanna, Claudia, Stéphenne, Xavier, Revencu, Nicole, Smets, Françoise, Sassolas, Agnes, Di Filippo, Mathilde, Descamps, Olivier S, Sokal, Etienne M

“…Abstract Familial hypercholesterolemia (FH) is a co-dominantly inherited disorder of plasma lipoprotein metabolism. The prevalence of heterozygous FH (HeFH) is…”
Get full text

A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy) by Descamps, Olivier S., Van Caenegem, Olivier, Hermans, Michel P., Balligand, Jean-Luc, Beauloye, Christophe, Bondue, Antoine, Carlier, Stéphane, Castermans, Emilie, Chenot, Fabien, Claeys, Marc, De Block, Christophe, de Leener, Anne, De Meester, Antoine, Demeure, Fabian, De Raedt, Herbert, Desmet, Walter, Elegeert, Ivan, Guillaume, Michel, Hoffer, Etienne, Kacenelenbogen, Raymond, Lancellotti, Patrizio, Langlois, Michel, Leone, Attilio, Mertens, Ann, Paquot, Nicolas, Vanakker, Olivier, Vanoverschelde, Jean-Louis, Verhaegen, Ann, Vermeersch, Pieter, Wallemacq, Caroline, Rietzschel, Ernst

“…Familial hypercholesterolaemia (FH) is an autosomal dominant lipoprotein disorder characterized by significant elevation of low-density lipoprotein cholesterol…”
Get full text

Familial hypercholesterolaemia in a Belgian community by DESCAMPS, Olivier S

“…Familial hypercholesterolaemia (FH) is a genetic disease in which low-density lipoproteins are defectively removed from plasma as a result of mutations that…”
Get full text

Lipoprotein(a) as a cardiovascular risk factor: current status by Nordestgaard, Børge G., Chapman, M. John, Ray, Kausik, Borén, Jan, Andreotti, Felicita, Watts, Gerald F., Ginsberg, Henry, Amarenco, Pierre, Catapano, Alberico, Descamps, Olivier S., Fisher, Edward, Kovanen, Petri T., Kuivenhoven, Jan Albert, Lesnik, Philippe, Masana, Luis, Reiner, Zeljko, Taskinen, Marja-Riitta, Tokgözoglu, Lale, Tybjærg-Hansen, Anne

“…Aims The aims of the study were, first, to critically evaluate lipoprotein(a) [Lp(a)] as a cardiovascular risk factor and, second, to advise on screening for…”
Get full text